Dose-Dependent Efficacy and Safety of Tirzepatide for Weight Loss in Non-diabetic Adults With Obesity: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Ipamorelin is notable for its selectivity, unlike other GHS-R agonists, research indicates it produces minimal effects on ACTH, cortisol, or prolactin in research models (Raun et al., Endocrinology, 1998)
Extension studies have followed patients for multiple years with continued efficacy and safety
For people managing type 2 diabetes, Semaglutide and Tirzepatide can improve blood sugar levels, reduce insulin resistance, and lower cardiovascular risks
It comes down to one question: do you have skin laxity, or do you have skin excess
GLP-1 medication therapy may be appropriate for men experiencing challenges with weight management or metabolic health